Aspira Women's Health INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Aspira Womens Health Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, stock incentive plan amendments, and auditor ratification.
Aspira Women's Health is seeking shareholder approval on key proposals including director elections, executive compensation, a stock incentive plan amendment, and ratification of its accounting firm at its upcoming annual meeting.
Aspira Women's Health is holding its annual meeting to vote on key proposals including a reverse stock split, director elections, executive compensation, and amendments to its stock incentive plan.
DEFA14A: Aspira Womens Health Inc. Updates Stock Incentive Plan and Announces General Counsel's Resignation
Aspira Womens Health Inc. supplements its proxy statement to include the amended 2019 Stock Incentive Plan and discloses the resignation of its General Counsel, effective May 6, 2024.
Aspira Women's Health Inc. will hold its annual stockholders meeting virtually on June 22, 2021, to vote on the election of directors, executive compensation, and the ratification of the company's accounting firm.
Aspira Women's Health is holding its annual meeting on May 13, 2024, to vote on director elections, executive compensation, an amendment to the stock incentive plan, and ratification of the independent accounting firm.